Choroidal neovascularization in a young, healthy eye after LASIK

Size: px
Start display at page:

Download "Choroidal neovascularization in a young, healthy eye after LASIK"

Transcription

1 Optometry (2010) 81, Choroidal neovascularization in a young, healthy eye after LASIK Bharti Bathija-Lala, O.D., a Sherry J. Bass, O.D., a Richard J. Madonna, O.D., a and Alan Dayan, M.D. b a State University of New York State College of Optometry, New York, New York; and b New York Eye and Ear Infirmary, New York, New York. KEYWORDS Choroidal neovascularization; Laser-in-situ keratomileusis (LASIK); Myopia, macular hemorrhage Abstract BACKGROUND: Choroidal neovascularization (CNV) is associated with age-related macular degeneration (AMD), degenerative myopia, angioid streaks, presumed ocular histoplasmosis syndrome, and numerous other ocular and systemic conditions. Idiopathic CNV is also a common form of the condition. However, CNV has rarely been noted after laser-assisted in situ keratomileusis (LASIK) and a cause-and-effect relationship has not been found. A case of CNV after uneventful LASIK is reported here, along with a literature review of previously reported cases and suggested pathophysiology. A link between LASIK and CNV is sought. METHODS: A case report of CNV in a young, healthy eye after uneventful LASIK is presented. Review of the pertinent literature reporting a relationship between LASIK and CNV was conducted through 2007, and few studies are reported after CONCLUSION: To date, there is anecdotal evidence of CNV after LASIK. The incidence from prior reports ranges from 0.003% to 0.33%. However, a causal link cannot be disregarded and merits further study. Each patient undergoing LASIK warrants a thorough preoperative dilated fundus examination, including a thorough examination of the macula. This occurrence, albeit rare, should be considered for inclusion in the refractive surgery consent form. Optometry 2010;81: Choroidal neovascularization (CNV) involves new, fragile blood vessel growth that may leak, spontaneously involute, or scar over. CNV may occur in any retinal location: subfoveal, juxtafoveal, or extrafoveal. The most visually devastating is subfoveal because it is the most difficult to manage. 1 The development of CNV is associated with a number of retinal conditions, primarily age-related macular degeneration (AMD), degenerative myopia, angioid streaks, and Disclosure: The authors have no financial or other relationships that might lead to a conflict of interest. Corresponding author: Bharti Bathija-Lala, O.D., Mabrypark Place, Alpharetta, Georgia bbathija@gmail.com presumed ocular histoplasmosis syndrome (POHS). After AMD, idiopathic CNV is the second most common etiology. 2 Reports of CNV after laser-assisted in situ keratomileusis (LASIK) are rare. Table 1 lists the cases of CNV after LASIK in patients without and with predisposing factors. Table 2 lists the cases of macular involvement without CNV. Case report A 23-year-old white woman with no ocular or health history presented for a LASIK consultation. Her best-corrected visual acuity (VA) was 20/20 in both the right and left eyes. Cycloplegic refraction showed diopters (D) in each /$ - see front matter Ó 2010 American Optometric Association. All rights reserved. doi: /j.optm

2 Table 1 CNV after LASIK in patients with and without predisposing factors Study Year Preoperative prescription Age (y) Sex Predisposing factors Time s/p LASIK Eye CNV location Treatment Outcome NO PREDISPOSING FACTORS Saeed et al Pinto et al x180 20/ x155 20/ / /25 Arevalo SE 20/ SE 20/ / / / / / / VA? VA? Arevalo et al ,916 cases Chen et al x7 37 M 3 mo O.S. Subfoveal 6/60 64 M AMD 3 mo O.S. Extrafoveal Argon then PDT 20/ F 3 wk O.S. Subfoveal None 20/50 28 F None 3 y O.D. Subfoveal PDT x 3 20/ F None 3 y O.D. Subfoveal PDT 20/40 47 F Focal RPE 4 y O.S. Subfoveal PDT x 2 20/100 atrophy O.S. 38 F None 5 y O.S. Subfoveal PDT 20/ F None 2 y O.S. Subfoveal PDT x 2 20/200 None 2 y O.S. Juxtafoveal Vitrectomy-retinotomy CF 32 M None 4 wk OU Subfoveal OU x179 Maturi et al d OU Subfoveal; Lacquer cracks PREDISPOSING FACTORS Ellies et al /50 32 F None 4 d O.S. Mac Heme (-) CNV Sobha et al / x125 6/ F Fuch s spot 1 d O.D. Subfoveal. 20/200 Federovic et al Moderate myopia 61 M O.D. perifoveal spot 12 wk O.D. OU Extrafoveal PDTx2 Scarring 8 wk O.S. Ruiz-Moreno et al /50 41 M 2 y O.D. Extrafoveal Argon 20/ /20 O.S /20 30 F O.D. Juxtafoveal CNV O.S. Lacquer cracks 3mo 9mo OU Subfoveal Juxtafoveal Argon O.S. 20/800 20/ OU 20/50 36 M 1 y O.S. Subfoveal Excision 20/200 Note. Table shows patients who had choroidal neovascularization after LASIK. These patients include those with and without predisposing factors for the development of CNV. eye; OU 5 both eyes; s/p 5 status post; SE 5 spherical equivalent; CF 5 counting fingers. 20/80 O.D. 5 right eye; O.S. 5 left Bathija-Lala et al Issue Highlight 633

3 634 Optometry, Vol 81, No 12, December 2010 Table 2 Macular complications, excluding CNV, after LASIK Study Year Refractive error Age Sex Luna et al x x55 Ruiz-Moreno, SE 20/32 Montero et al SE 20/28 Singhvi et al Principe et al MACULAR HEMES/INVOLVEMENT Predisposing factors 31 M 1 d 17 d Time after LASIK Eye Macula Final VA OU OU mac hemes 1 venous congestion 37 F 2 mo O.D. Mac heme 1 Lacquer crack (-) CNV RPE CSR OU atrophy OU 36 F O.S. Mac Heme (-) CNV 20/60 20/50 Note. Table shows other complications that occurred in the macula of patients who underwent LASIK. These patients did not have choroidal neovascularization. O.D. 5 right eye; O.S. 5 left eye; OU 5 both eyes; CSR 5 central serous retinopathy. 20/25 20/25 eye. The anterior segment structures were normal. Central corneal thickness (CCT) was 518 mm in the right eye and 525 mm in the left eye. Examination of the retinas did not find any macular or peripheral abnormalities in either eye. She subsequently underwent uneventful, simultaneous bilateral LASIK. At her 1-day postoperative visit, her uncorrected VA was 20/20 in the right eye and 20/25 in the left eye, which was correctable to 20/20 with D sphere. At her 6-week follow-up visit, her uncorrected VA in the right eye was still 20/20 but was best corrected to only 20/60 in the left eye. She noted that the Snellen optotypes appeared wavy. The patient was not aware of this decrease in vision. Amsler grid testing of the left eye found a 3 area of metamorphopsia slightly superior to fixation. The corneal flaps and anterior segment were found to be normal in both eyes. A dilated fundus examination found a serous macular detachment with a greenish-grey pigmented area inferior to the macula in the left eye (see Figure 1). Fluorescein angiography (FA) found a classic, juxtafoveal choroidal neovascular net inferonasal to the fovea in the left eye (see Figure 2). The right eye was normal. Ocular coherence tomography (OCT) of the left eye found a highly reflective area above the retinal pigment epithelium inferonasal to the fovea with an overlying serous detachment (see Figure 3). Accordingly, the left eye was treated with 1 course of photodynamic therapy (PDT) and an intravitreal injection of triamcinolone acetonide. Over the next 4 weeks, the fluid resorbed, and the VA in the left eye improved to 20/25, but the macula retained a mottled pigmentary appearance (see Figure 4). Further follow-up over a 2-year period has not found any additional recurrence in the left eye and no similar development in the right eye. Currently, her VA in the left eye has stabilized to 20/20 (see Figure 5). Discussion Review of the literature divides cases of CNV after LASIK into those with no predisposing factors and those with predisposing factors. Predisposing factors include, but are not limited to, (1) high myopia, (2) angioid streaks, (3) AMD, (4) prior retinal laser treatment, (5) age-related macular mottling, (6) Fuch s spot, (7) lacquer cracks, and (8) POHS. CNV after LASIK: no predisposing factors Patients without predisposing factors in whom CNV develops after LASIK ranged in age from 27 to 64 years. Figure 1 Macular fluid and an area of green grey pigmentation inferonasal to the fovea in the left eye with visual acuity of 20/60.

4 Bathija-Lala et al Issue Highlight 635 The patients in whom CNV developed included both myopes and hyperopes, although the preponderance of cases was found in the moderate myopes. The incidence of CNV after LASIK in these studies ranged from 0.003% to 0.33%. 6 None of the above studies reported the CCT values of the affected patients. Proposed mechanism of development of CNV after LASIK Figure 2 Fluorescein angiography shows a small classic subfoveal choroidal neovascular membrane in the left eye. The CNV developed anywhere from 1 day to 5 years after LASIK and tended to present as subfoveal membranes. Preoperative refractive errors ranged from D to D, with the majority of cases taking place in the moderate myopes Of interest, in the Arevalo 6 (2000) study of 29,916 cases, only 1 patient had CNV, representing an incidence of 0.003%, and this patient had a hyperopic refractive error (see Table 1). CNV: predisposing factors and macular involvement Patients with predisposing factors to CNV ranged in age from 30 to 61 years and had preoperative refractive errors from D to D. Predisposing factors in these studies included Fuch s spot, lacquer cracks, POHS, and previous CNV. Patients with macular involvement had macular hemorrhages, lacquer cracks, venous congestion, and central serous retinopathy, but no CNV. Their ages ranged from 31 to 37 years with preoperative refractive errors ranging from D to D (see Table 2). Of the cases cited in the Table 1, 1 factor occurred in both the hyperopic and myopic patient: CNV developed after LASIK. Although a direct cause effect relationship is unclear, 2 major mechanisms have been proposed to explain the development of CNV after LASIK. The LASIK procedure can be divided into 3 major phases. The first phase involves the creation of the flap with a microkeratome, which requires a temporary but significant increase in intraocular pressure. The second phase involves photocoagulation of the stromal bed, and the third phase is repositioning of the flap. It is during the first 2 phases in which the eye is stressed the most that the answer may lie. Phase 1: flap creation. It is postulated that the increase in eye pressure during flap formation creates a mechanical force, a tangential stress, which may encourage or enhance breaks in Bruch s membrane with subsequent development of CNV. According to the manufacturer of the microkeratome, it is believed that eye pressure has to exceed 65 mmhg to create the vacuum allowing the microkeratome ring to suction onto the cornea. 12 It has been proposed that the suction ring may exert its effect up to 4 mm posterior to the limbus. 6 Thus, LASIK can be thought of as a trauma to the eye in the form of increased intraocular pressure (IOP) delivering a blow to the retina. Maturi et al. 8 utilizes LaPlace s law (T 5 PR/2) to explain the relationship between macular hemorrhages and CNV after LASIK. An increase in wall tension (T) will increase axial length (R 5 half of axial length). Maturi Figure 3 OCT shows a serous detachment and highly reflective area above the retinal pigment epithelium.

5 636 Optometry, Vol 81, No 12, December 2010 Figure 4 20/25. The left eye 4 weeks after treatment with PDT and 1 intravitreal injection of Kenalog. The serous detachment has resolved, and visual acuity is et al. 8 cite a private communication in which they report that IOP (P) increases to 100 mmhg, and not 65 mmhg, during the creation of the flap. This results in a 27% greater wall tension than some myopic eyes may be able to tolerate. The increased tension, caused by the increased eye pressure, may cause breaks in Bruch s membrane with subsequent hemorrhaging and CNV in the macula. Sobha et al. 10 stated that hyperopic patients generally do not have any predisposition for the development of CNV. Typically, they have no breaks in Bruch s membrane or other factors associated with CNV growth. However, the patient in their report was 61 years old and therefore had age as an influencing factor. The patient may have had subclinical age-related weakening of Bruch s membrane. They postulate that the pressure differential caused by the microkeratome may be the etiologic agent for inducing growth of CNV. Ruiz-Moreno et al. 12 believe that a myopic fundus has retinal abnormalities related to the elongation of axial length that predispose the development of CNV. For example, they note that lacquer cracks are found in 83% of eyes with CNV. On average, the growth rate of CNV is 10 mm per day. 12 In their patient, CNV developed 8 months after LASIK, but given its size, the CNV should have appeared earlier, i.e., 4 months postoperatively. Because of this time discrepancy, Ruiz-Moreno et al. 12 believe the CNV may be related to the existing degenerative myopia and not to LASIK. However, they too offer a similar theory of increased IOP as a possible etiology in their patient. Phase 2: photoablation of the stromal bed. The other proposed mechanism is that of the creation of acoustic waves. Pulsed ablation of the stromal bed by the laser sets up acoustic stress waves along the axis of the eye. These shock waves travel from the anterior segment through the posterior segment. Ruiz-Moreno et al. 12 states that the stress wave amplitudes reach a maximum pressure focus of 100 atmospheres in the posterior lens and anterior vitreous. The pressure focus then dissipates to less than 10 atmospheres by the time it reaches the retina or posterior segment. Even at 10 atmospheres, this acoustic shock wave may be responsible for creating disruptions in Bruch s membrane, thereby facilitating CNV growth in some patients. Sobha et al. 10 supported the findings of Ruiz-Moreno et al., 12 citing the incidence of CNV after photorefractive keratectomy as 0.01% and 0.33% after LASIK. Sobha et al. 10 speculate that the difference in incidence may be attributed to the different modality used to perform the procedure. Influence of central corneal thickness Figure 5 Two years later, the left eye remains quiescent with no recurrences. Persistent pigment abnormalities remain inferonasally, but visual acuity is maintained at 20/20. Although none of the cited studies reported central corneal thickness (CCT) or investigated its role in the development of CNV after LASIK in their patients, our patient is notable for

6 Bathija-Lala et al Issue Highlight 637 having a CCT that is thinner than average. The question remains whether a thinner-than-average cornea represents another risk factor for the development of CNV after LASIK because it may be less resilient to the stresses placed on the eye by the flap creation and photoablation. Because thin corneas place some eyes at risk for glaucoma, 17 such eyes may also be at risk for retinal problems, especially when stressed, as during LASIK. Further studies may be warranted. Other posterior segment complications after LASIK In addition to CNV, other posterior segment complications 18 have been reported after LASIK. These include retinal tears and retinal detachment, posterior vitreal detachment, 17 increased neovascularization in proliferative diabetic retinopathy, 22 and ischemic complications of other vascular disease. 2 These changes are postulated to be caused by a transient elongation of the axial length during ring suction. Conclusion Millions of LASIK procedures have been performed worldwide, and a majority of these are successful. The incidence of post-lasik CNV is very low, ranging from 0.003% to 0.33%. 6 The causal link between CNV development after LASIK has not been proven but cannot be disregarded. Although rare, more studies of this relationship are warranted. 23 A detailed preoperative dilated fundus examination, with careful attention to the macula, should be done on every patient undergoing LASIK. In light of the cited studies, it is worthwhile to note that even a low myope with no risk factors reportedly had CNV after LASIK. Although most complications after LASIK are associated with the flap and corneal interface, 24 the inclusion of the development of CNV, however unlikely, on the consent form, should be considered. Alternatives such as cataract surgery with replacement with a PC IOL 25 may be more suitable for patients with high refractive errors and thin corneas, although this procedure is not without retinal risk. In addition, patients with preexisting risk factors for CNV, e.g., Fuch s spot, atrophic macular degeneration, diabetic retinopathy, or POHS, should be counseled on the increased possibility of CNV development after LASIK and may also want to consider alternative refractive surgery options. As for the healthy, young eye with no predisposing factors, the development of CNV, albeit rare, can occur, and patients should be counseled accordingly. References 1. Browning DJ, Fraser CM. Ocular conditions associated with peripapillary subretinal neovascularization: Their relative frequencies and associated conditions. Ophthalmology 2005;112: Alexander L. Primary care of the posterior segment, Third ed. Spain: McGraw-Hill; Saeed M, Poon W, Goyal S, et al. Choroidal neovascularization after laser in situ keratomileusis in a patient with low myopia. J Cataract Refract Surg 2004;30(12): Pinto RVB, Smiddy WE, Culbertson W. Choroidal neovascularization following laser in situ keratomileusis. Ophthalmic Surg Laser Imaging 2005;35(1): Arevalo JF. Retinal complications after laser-assisted in situ keratomileusis (LASIK). Curr Opin Opthalmol 2004;15: Arevalo JF, Ramirez E, Suarez E, et al. Incidence of vitreoretinal pathologic conditions within 24 months after laser in situ keratomileusis. Ophthalmology 2000;107(12): Chen YC, Ma DHK, Yang KJ, et al. Bilateral choroidal neovascularization after laser-assisted in situ keratomileusis. Retina 2001;21(2): Maturi RJ, Kitchens JW, Spitzberg DH, et al. Choroidal neovascularization after LASIK. J Cataract Refract Surg 2003;19(4): Ellies P, Pietrinin D, Lumbroso L, et al. Macular hemorrhage after laser in situ keratomileusis for high myopia. J Cataract Refract Surg 2000;26(6): Sobha S, Rajan MS, Jackson H. Choroidal neovascularization following hyperopic LASIK surgery. Clin Exp Ophthalmol 2004;32: Federovich I, Mehr DS, Akduman L. Choroidal neovascularization after laser in situ keratomileusis in a patient with presumed ocular histoplasmosis syndrome. Eur J Ophthalmol 2004;14(3): Ruiz-Moreno JM, Perez-Santonja JJ, Alio JL. Choroidal neovascularization in myopic eyes after laser-assisted in situ keratomileusis. Retina 2001;21(21): Luna JD, Reviglio VE, Juarez CP. Bilateral macular hemorrhage after laser in situ keratomilesis. Graefe s Arch Clin Exp Ophthalmol 1999; 237: Ruiz-Moreno JM, Montero J, Alio JL. Lacquer crack formation after LASIK. Ophthalmology 2003;110(8): Singhvi A, Dutta M, Sharma N, et al. Bilateral serous macular detachment following laser in situ keratomileusis. Am J Ophthalmol 2004; 138: Principe AH, Lin DY, Small KW, et al. Macular hemorrhage after laser in situ keratomileusis with femtosecond laser flap creation. Am J Ophthalmol 2004;138: Gordon MO, Beiser JA, Brandt JD, et al, for the Ocular Hypertension Treatment Study Group. The ocular hypertension treatment study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120: Luna JD, Artal MN, Reviglio VE, et al. Vitreoretinal alteration following laser in situ keratomileusis: clinical and experimental studies. Graefe s Arch Clin Exp Ophthalmol 2001;239: Arevalo JF, Ruiz-Moreno JM, Fernandez CF, et al. Photodynamic therapy with verteporfin for subfoveal choroidal neovascular membranes in highly myopic eyes after laser in situ keratomileusis. Ophthalmic Surg Laser Imaging 2005;35(1): Flaxel CJ, Choi YH, Sheety M, et al. Proposed mechanism for retinal tears after LASIK. Ophthalmology 2003;110(8): Mostafavi D, Fekrat S, Toth CA, et al. Letter to editor: LASIK and vitreous pathology after LASIK. Ophthalmology 2002;109: Ghanbari H, Ahmadieh H. Aggravation of proliferative diabetic retinopathy after laser in situ keratomileusis. J Cataract Refract Surg 2003;29: Bailey CS. Editorial response to Choroidal neovascularization after laser in situ keratomileusis in a patient with low myopia. J Cataract Refract Surg 2005;31: Stulting RD, Carr JD, Thompson KP, et al. Complications of laser in situ keratomileusis for the correction of myopia. Ophthalmology 1999; 106: Lowenstein A, Goldstein M, Lazar M. Retinal pathology occurring after excimer laser surgery or phakic intraocular lens implantation: Evaluation of possible relationship. Surv Ophthalmol 2002;17:

Retina Conference. Janelle Fassbender, MD, PhD University of Louisville Department of Ophthalmology and Visual Sciences 09/04/2014

Retina Conference. Janelle Fassbender, MD, PhD University of Louisville Department of Ophthalmology and Visual Sciences 09/04/2014 Retina Conference Janelle Fassbender, MD, PhD University of Louisville Department of Ophthalmology and Visual Sciences 09/04/2014 Subjective CC/HPI: 64 year old Caucasian female referred by outside ophthalmologist

More information

ZEISS AngioPlex OCT Angiography. Clinical Case Reports

ZEISS AngioPlex OCT Angiography. Clinical Case Reports Clinical Case Reports Proliferative Diabetic Retinopathy (PDR) Case Report 969 PROLIFERATIVE DIABETIC RETINOPATHY 1 1-year-old diabetic female presents for follow-up of proliferative diabetic retinopathy

More information

Clinical Study The Incidence of Central Serous Chorioretinopathy after Photorefractive Keratectomy and Laser In Situ Keratomileusis

Clinical Study The Incidence of Central Serous Chorioretinopathy after Photorefractive Keratectomy and Laser In Situ Keratomileusis Hindawi Publishing Corporation Journal of Ophthalmology Volume 2012, Article ID 904215, 5 pages doi:10.1155/2012/904215 Clinical Study The Incidence of Central Serous Chorioretinopathy after Photorefractive

More information

FEEDER VESSEL TREATMENT

FEEDER VESSEL TREATMENT THERAPEUTIC OPTIONS FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION * Discussion led by Donald J. D'Amico, MD Dr D Amico: The overview articles in this monograph highlight findings from clinical trials

More information

DOME SHAPED MACULOPATHY. Ιωάννης Ν. Βαγγελόπουλος Χειρ. Οφθαλμίατρος - Βόλος

DOME SHAPED MACULOPATHY. Ιωάννης Ν. Βαγγελόπουλος Χειρ. Οφθαλμίατρος - Βόλος DOME SHAPED MACULOPATHY Ιωάννης Ν. Βαγγελόπουλος Χειρ. Οφθαλμίατρος - Βόλος DOME SHAPED MACULOPATHY-DEFINITIONS The entity Dome Shaped Macula ( DSM ) was first described by Gaucher and associates in 2008

More information

Ophthalmology Macular Pathways

Ophthalmology Macular Pathways Ophthalmology Macular Pathways Age related Macular Degeneration Diabetic Macular Oedema Macular Oedema secondary to Central Retinal Macular Oedema secondary to Branch Retinal CNV associated with pathological

More information

Department of Ophthalmology, Kangnam Sacred Heart Hospital, College of Medicine, Hallym University, Seoul, Korea

Department of Ophthalmology, Kangnam Sacred Heart Hospital, College of Medicine, Hallym University, Seoul, Korea Department of Ophthalmology, Kangnam Sacred Heart Hospital, College of Medicine, Hallym University, Seoul, Korea Purpose: To investigate the factors that affect final vision following photodynamic therapy

More information

R&M Solutions

R&M Solutions Mohamed Hosny El-Bradey, MD., Assistant Professor of Ophthalmology, Tanta University. Wael El Haig, MD., Professor of Ophthalmology. Zagazeeg University. 1 Myopic CNV is considered the most common vision

More information

IQ 532 Micropulse Green Laser treatment for Refractory Chronic Central Serous Retinopathy

IQ 532 Micropulse Green Laser treatment for Refractory Chronic Central Serous Retinopathy Cronicon OPEN ACCESS EC OPHTHALMOLOGY Case Report IQ 532 Micropulse Green Laser treatment for Refractory Chronic Central Serous Retinopathy Fawwaz Al Mamoori* Medical Retina Department, Eye Specialty Hospital,

More information

Stabilization of visual acuity with photodynamic therapy in eyes with chorioretinal anastomoses

Stabilization of visual acuity with photodynamic therapy in eyes with chorioretinal anastomoses Graefe s Arch Clin Exp Ophthalmol (2004) 242:368 376 CLINICAL INVESTIGATION DOI 10.1007/s00417-003-0844-0 Rufino M. Silva José R. Faria de Abreu António Travassos José G. Cunha-Vaz Stabilization of visual

More information

Clinical Study Choroidal Thickness in Eyes with Unilateral Ocular Ischemic Syndrome

Clinical Study Choroidal Thickness in Eyes with Unilateral Ocular Ischemic Syndrome Hindawi Publishing Corporation Journal of Ophthalmology Volume 215, Article ID 62372, 5 pages http://dx.doi.org/1.1155/215/62372 Clinical Study Choroidal Thickness in Eyes with Unilateral Ocular Ischemic

More information

Myopic Choroidal Neovascularization

Myopic Choroidal Neovascularization Myopic Choroidal Neovascularization A 10-year Follow-up Takeshi Yoshida, MD, Kyoko Ohno-Matsui, MD, Kenjiro Yasuzumi, MD, Ariko Kojima, MD, Noriaki Shimada, MD, Soh Futagami, MD, Takashi Tokoro, MD, Manabu

More information

Clear Lens Extraction for Correction of High Myopia

Clear Lens Extraction for Correction of High Myopia Original Article Clear Lens Extraction for Correction of High Myopia Abbas Abolhasani 1, MD; Mostafa Heidari *2, MS; Ahmad Shojaei 1, MD; Seyed Hashem Khoee 1, MD; Mahmoud Rafati 1, MD; Ali Moradi 1, MS

More information

Retinal Complications of Obstructive Sleep Apnea A Growing Concern!

Retinal Complications of Obstructive Sleep Apnea A Growing Concern! Retinal Complications of Obstructive Sleep Apnea A Growing Concern! Jay M. Haynie, OD, FAAO Financial Disclosure I have received honoraria or am on the advisory board for the following companies: Carl

More information

Authors. Introduction. Introduction. Materials and Methods. Objective 10/27/2015

Authors. Introduction. Introduction. Materials and Methods. Objective 10/27/2015 Idiopathic Polypoidal Choroidal Vasculopathy (IPCV) in Thai Population Presenting with Choroidal Neovascularization (CNV) A multicenter study Authors Yonrawee Piyacomn 1, Chavakij Bhoomibunchoo 1, Yosanan

More information

펨토초레이저와미세각막절삭기를이용한근시교정수술에서임상성적비교

펨토초레이저와미세각막절삭기를이용한근시교정수술에서임상성적비교 펨토초레이저와미세각막절삭기를이용한근시교정수술에서임상성적비교 4 Table. Summary of data about patient who had LASIK operation using second laser and keratome Age (years) Male:Female (eyes) Pre-op. IOP (mmhg) Pre-op SE * (D) Pre-op

More information

OCT Angiography in Primary Eye Care

OCT Angiography in Primary Eye Care OCT Angiography in Primary Eye Care An Image Interpretation Primer Julie Rodman, OD, MS, FAAO and Nadia Waheed, MD, MPH Table of Contents Diabetic Retinopathy 3-6 Choroidal Neovascularization 7-9 Central

More information

Clinically Significant Macular Edema (CSME)

Clinically Significant Macular Edema (CSME) Clinically Significant Macular Edema (CSME) 1 Clinically Significant Macular Edema (CSME) Sadrina T. Shaw OMT I Student July 26, 2014 Advisor: Dr. Uwaydat Clinically Significant Macular Edema (CSME) 2

More information

CASE STUDIES CURRENT AND FUTURE TREATMENT OPTIONS FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION * Discussion led by Neil M.

CASE STUDIES CURRENT AND FUTURE TREATMENT OPTIONS FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION * Discussion led by Neil M. CURRENT AND FUTURE TREATMENT OPTIONS FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION * Discussion led by Neil M. Bressler, MD Dr Bressler: The overview articles in this monograph summarize safety, efficacy,

More information

Posterior Segment Update

Posterior Segment Update Posterior Segment Update Featured Speaker: Dr. Kyle Cheatham, FAAO, DIP ABO DISCLOSURE STATEMENT We have no direct financial or proprietary interest in any companies, products or services mentioned in

More information

HIGH DOSE TISSUE PLASMINOGEN ACTIVATOR (TPA) (100 MCG/0.1 ML) AND C3F8 GAS IN PNEUMATIC DISPLACEMENT OF SUBMACULAR

HIGH DOSE TISSUE PLASMINOGEN ACTIVATOR (TPA) (100 MCG/0.1 ML) AND C3F8 GAS IN PNEUMATIC DISPLACEMENT OF SUBMACULAR HIGH DOSE TISSUE PLASMINOGEN ACTIVATOR (TPA) (100 MCG/0.1 ML) AND C3F8 GAS IN PNEUMATIC DISPLACEMENT OF SUBMACULAR HAEMORRHAGE. Stephen A.M. De Souza MD, FRCSC Matthew J Welch MD, Raza M Shah MD, Alan

More information

Recurrent intraocular hemorrhage secondary to cataract wound neovascularization (Swan Syndrome)

Recurrent intraocular hemorrhage secondary to cataract wound neovascularization (Swan Syndrome) Recurrent intraocular hemorrhage secondary to cataract wound neovascularization (Swan Syndrome) John J. Chen MD, PhD; Young H. Kwon MD, PhD August 6, 2012 Chief complaint: Recurrent vitreous hemorrhage,

More information

Opinion 4 December 2013

Opinion 4 December 2013 The legally binding text is the original French version TRANSPARENCY COMMITTEE Opinion 4 December 2013 LUCENTIS 10 mg/ml, solution for injection Vial of 0.23 ml (CIP: 34009 378 101 5 9) Applicant: Novartis

More information

NEPTUNE RED BANK BRICK

NEPTUNE RED BANK BRICK NEPTUNE RED BANK BRICK Diabetes & The Eye Diabetics are more likely to develop Cataracts at a younger age. Diabetics are twice as likely to develop Glaucoma when compared to non-diabetics. The primary

More information

11/29/2016 MACULAR MALADIES: TYPICAL & ATYPICAL CASES

11/29/2016 MACULAR MALADIES: TYPICAL & ATYPICAL CASES MACULAR MALADIES: TYPICAL & ATYPICAL CASES Dawn Pewitt, OD, FAAO Triad Eye Institute, Grove, OK Dpewitt@triadeye.com Disclosure Statement: No financial disclosures COPE 51218-PS Please silence all mobile

More information

THE OCULAR histoplasmosis

THE OCULAR histoplasmosis CLINICAL SCIENCES Reactivation of Inflammatory Lesions in Ocular Histoplasmosis David Callanan, MD; Gary E. Fish, MD, JD; Rajiv Anand, MD Background: Active inflammation has not been traditionally associated

More information

Although photocoagulation and photodynamic PROCEEDINGS PEGAPTANIB SODIUM FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION *

Although photocoagulation and photodynamic PROCEEDINGS PEGAPTANIB SODIUM FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION * PEGAPTANIB SODIUM FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION Evangelos S. Gragoudas, MD ABSTRACT In December 24, the US Food and Drug Administration (FDA) approved pegaptanib sodium. Pegaptanib

More information

OPHTHALMOLOGICAL DISORDERS

OPHTHALMOLOGICAL DISORDERS Telephone No.: 24622495 Telegraphic Address: Aeronautical: VIDDYAYX Commercial: AIRCIVIL NEW DELHI E Mail: dri@dgca.nic.in Fax:01124629211 GOVERNMENT OF INDIA AERONAUTICAL INFORMATION SERVICE DIRECTOR

More information

MEDICAL POLICY SUBJECT: CORNEAL ULTRASOUND PACHYMETRY. POLICY NUMBER: CATEGORY: Technology Assessment

MEDICAL POLICY SUBJECT: CORNEAL ULTRASOUND PACHYMETRY. POLICY NUMBER: CATEGORY: Technology Assessment MEDICAL POLICY SUBJECT: CORNEAL ULTRASOUND,, PAGE: 1 OF: 5 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including

More information

Intraocular Radiation Therapy for Age-Related Macular Degeneration

Intraocular Radiation Therapy for Age-Related Macular Degeneration Medical Policy Manual Medicine, Policy No. 134 Intraocular Radiation Therapy for Age-Related Macular Degeneration Next Review: April 2019 Last Review: June 2018 Effective: August 1, 2018 IMPORTANT REMINDER

More information

Choroidal detachment following retinal detachment surgery: An analysis and a new hypothesis to minimize its occurrence in high-risk cases

Choroidal detachment following retinal detachment surgery: An analysis and a new hypothesis to minimize its occurrence in high-risk cases European Journal of Ophthalmology / Vol. 14 no. 4, 2004 / pp. 325-329 Choroidal detachment following retinal detachment surgery: An analysis and a new hypothesis to minimize its occurrence in high-risk

More information

When optical coherence tomography (OCT)

When optical coherence tomography (OCT) Macular Imaging: SD-OCT in nterior Segment Surgical Practice Many pathologic processes of the macula can be visualized or quantified only with this modality. y Steven G. Safran, MD When optical coherence

More information

OCCLUSIVE VASCULAR DISORDERS OF THE RETINA

OCCLUSIVE VASCULAR DISORDERS OF THE RETINA OCCLUSIVE VASCULAR DISORDERS OF THE RETINA Learning outcomes By the end of this lecture the students would be able to Classify occlusive vascular disorders (OVD) of the retina. Correlate the clinical features

More information

Optical Coherence Tomography Findings in Highly Myopic Eyes following Cataract Surgery

Optical Coherence Tomography Findings in Highly Myopic Eyes following Cataract Surgery Optical Coherence Tomography Findings in Highly Myopic Eyes following Cataract Surgery Fedra Hajizadeh, MD 1 Mohammad Riazi Esfahani, MD 1,2 Hooshang Faghihi, MD 3 Mehdi Khanlari, MD 4 Abstract Purpose:

More information

연령연관황반변성에서망막혈관종성증식과동반된망막색소상피박리의임상양상과일차적인광역학치료의결과

연령연관황반변성에서망막혈관종성증식과동반된망막색소상피박리의임상양상과일차적인광역학치료의결과 연령연관황반변성에서망막혈관종성증식과동반된망막색소상피박리의임상양상과일차적인광역학치료의결과 40 Table. Clinical characteristics and results of patients undergoing photodynamic therapy for retinal angiomatous proliferation Patients No. Age/ sex Eye

More information

MEDICAL POLICY SUBJECT: PHOTODYNAMIC THERAPY FOR EFFECTIVE DATE: 07/20/00 SUBFOVEAL CHOROIDAL NEOVASCULARIZATION

MEDICAL POLICY SUBJECT: PHOTODYNAMIC THERAPY FOR EFFECTIVE DATE: 07/20/00 SUBFOVEAL CHOROIDAL NEOVASCULARIZATION MEDICAL POLICY SUBJECT: PHOTODYNAMIC THERAPY FOR PAGE: 1 OF: 8 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including

More information

Ocular Complications after Intravitreal Bevacizumab Injection in Eyes with Choroidal and Retinal Neovascularization

Ocular Complications after Intravitreal Bevacizumab Injection in Eyes with Choroidal and Retinal Neovascularization Original Article Ocular Complications after Intravitreal Bevacizumab Injection in Eyes with Choroidal and Retinal Neovascularization Aimal Khan, P.S Mahar, Azfar Nafees Hanfi, Umair Qidwai Pak J Ophthalmol

More information

Choroidal Neovascularization in Sympathetic Ophthalmia

Choroidal Neovascularization in Sympathetic Ophthalmia Choroidal Neovascularization in Sympathetic Ophthalmia Lucia Sobrin, Miguel Cordero Coma, C. Stephen Foster Case Report A 49-year-old man presented after a ruptured globe repair of his left eye status

More information

Doc, I See a Donut in My Vision : An Optometrist s Guide to a Rare Cause of Choroidal Neovascular Membrane

Doc, I See a Donut in My Vision : An Optometrist s Guide to a Rare Cause of Choroidal Neovascular Membrane Doc, I See a Donut in My Vision : An Optometrist s Guide to a Rare Cause of Choroidal Neovascular Membrane Linda Pham, OD, Tobin Ansel, OD, Nancy Shenouda-Awad, OD, FAAO, West Haven VA Medical Center Abstract

More information

Michael P. Blair, MD Retina Consultants, Ltd Libertyville/Des Plaines, Illinois Clinical Associate University of Chicago 17 October 2015

Michael P. Blair, MD Retina Consultants, Ltd Libertyville/Des Plaines, Illinois Clinical Associate University of Chicago 17 October 2015 Michael P. Blair, MD Retina Consultants, Ltd Libertyville/Des Plaines, Illinois Clinical Associate University of Chicago 17 October 2015 So What Parts of the Eye Retina are Affected by VHL Neural tissue

More information

SUMMARY. Heather Casparis, MD,* and Neil M. Bressler, MD MARINA AND ANCHOR

SUMMARY. Heather Casparis, MD,* and Neil M. Bressler, MD MARINA AND ANCHOR The following are summaries of selected presentations and posters from the American Society of Retina Specialists and European VitreoRetinal Society Annual Meeting held September 9 13, 2006, in Cannes,

More information

Cataract Surgery in the Patient with a History of LASIK or PRK

Cataract Surgery in the Patient with a History of LASIK or PRK Cataract Surgery in the Patient with a History of LASIK or PRK #56996-RS April 2018 Sebastian Lesniak, MD Matossian Eye Associates None Disclosures Bio Matossian Eye Associates, Hopewell NJ, 7/2015 Present

More information

Author s Affiliation. Original Article. Visual outcomes after LASIK (laser-assisted in-situ keratomileusis) for various refractive errors.

Author s Affiliation. Original Article. Visual outcomes after LASIK (laser-assisted in-situ keratomileusis) for various refractive errors. Original Article Visual outcomes after LASIK (laser-assisted in-situ keratomileusis) for various refractive errors. Author s Affiliation Sobia Tufail Imran Ahmad Asad Aslam Khan Correspondence Author:

More information

Moncef Khairallah, MD

Moncef Khairallah, MD Moncef Khairallah, MD Department of Ophthalmology, Fattouma Bourguiba University Hospital Faculty of Medicine, University of Monastir Monastir, Tunisia INTRODUCTION IU: anatomic form of uveitis involving

More information

A retrospective nonrandomized study was conducted at 3

A retrospective nonrandomized study was conducted at 3 Department of Ophthalmology, Kangbuk Samsung Hospital, Sungkyunkwan University College of Medicine 1, Seoul, Korea Hangil Eye Hospital 2, Incheon, Korea Seoul National University Bundang Hospital 3, Seongnam,

More information

OCT Angiography: The Next Step in Retinal Imaging Jonathan Zelenak D.O.

OCT Angiography: The Next Step in Retinal Imaging Jonathan Zelenak D.O. OCT Angiography: The Next Step in Retinal Imaging Jonathan Zelenak D.O. Hillsdale Hospital Michigan State University Overview Evolution of OCT How does OCT angiography work? Clinical examples Potential

More information

Progressive Symptomatic Retinal Detachment Complicating Retinoschisis. Initial Reporting Questionnaire

Progressive Symptomatic Retinal Detachment Complicating Retinoschisis. Initial Reporting Questionnaire Progressive Symptomatic Retinal Detachment Complicating Retinoschisis In association with the British Ophthalmological Surveillance Unit Ethics ref: 13/NW/0037 Initial Reporting Questionnaire Case Definition:

More information

The MP-1 Microperimeter Clinical Applications in Retinal Pathologies

The MP-1 Microperimeter Clinical Applications in Retinal Pathologies The MP-1 Microperimeter Clinical Applications in Retinal Pathologies Nelson R. Sabates, MD Director, Retina/Vitreous Service Vice-Chairman Department of Ophthalmology University of Missouri Kansas City

More information

Recalcitrant Diabetic Macular Oedema: Therapeutic Options

Recalcitrant Diabetic Macular Oedema: Therapeutic Options December 2007 A. Giridhar et al. - Recalcitrant DME 451 CONSULTATION S E C T I O N Recalcitrant Diabetic Macular Oedema: Therapeutic Options Dr. Cyrus M Shroff 1, Dr. N S Muralidhar 2, Dr. R Narayanan

More information

measure of your overall performance. An isolated glucose test is helpful to let you know what your sugar level is at one moment, but it doesn t tell you whether or not your diabetes is under adequate control

More information

Spontaneous Large Serous Retinal Pigment Epithelial Tear

Spontaneous Large Serous Retinal Pigment Epithelial Tear This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License (www.karger.com/oa-license), applicable to the online version of the article

More information

Long-term Management of AMD. Motasem Al-latayfeh, MD Assistant Prof. Ophthalmology Hashemite University Jordan

Long-term Management of AMD. Motasem Al-latayfeh, MD Assistant Prof. Ophthalmology Hashemite University Jordan Long-term Management of AMD Motasem Al-latayfeh, MD Assistant Prof. Ophthalmology Hashemite University Jordan DEFINITION 1 Age-related macular degeneration (AMD) is a disorder of the macula characterized

More information

HHS Public Access Author manuscript Ophthalmic Surg Lasers Imaging Retina. Author manuscript; available in PMC 2016 January 14.

HHS Public Access Author manuscript Ophthalmic Surg Lasers Imaging Retina. Author manuscript; available in PMC 2016 January 14. High-Speed Ultrahigh-Resolution OCT of Bruch s Membrane in Membranoproliferative Glomerulonephritis Type 2 Mehreen Adhi, MD, Sarah P. Read, MD, PhD, Jonathan J. Liu, PhD, James G. Fujimoto, PhD, and Jay

More information

CLINICAL SCIENCES. Optical Coherence Tomography Findings in Myopic Traction Maculopathy

CLINICAL SCIENCES. Optical Coherence Tomography Findings in Myopic Traction Maculopathy Optical Coherence Tomography Findings in Myopic Traction Maculopathy Giacomo Panozzo, MD; Andrea Mercanti, MD CLINICAL SCIENCES Objective: To describe the features and incidence of epiretinal traction

More information

VMA at the macula resulting in VMT

VMA at the macula resulting in VMT Ocriplasmina for pharmacologic treatment in VMT Teresio Avitabile 1 Introduction PVD is a normal, physiologic process that occurs with aging; however, in some cases, PVD is incomplete Incomplete PVD localized

More information

Dehiscence of detached internal limiting membrane in eyes with myopic traction maculopathy with spontaneous resolution

Dehiscence of detached internal limiting membrane in eyes with myopic traction maculopathy with spontaneous resolution Hirota et al. BMC Ophthalmology 2014, 14:39 RESEARCH ARTICLE Open Access Dehiscence of detached internal limiting membrane in eyes with myopic traction maculopathy with spontaneous resolution Kazunari

More information

Number 80. Laser Eye Surgery in Myopia. Date of decision October 2017 Date of review October 2020 GUIDANCE

Number 80. Laser Eye Surgery in Myopia. Date of decision October 2017 Date of review October 2020 GUIDANCE Excluded: Procedure not routinely funded Bedfordshire, Hertfordshire, West Essex, Luton and Milton Keynes Priorities Forum statement - adapted for Bedfordshire CCG Number 80 Subject Date of decision October

More information

Mitsuko Yuzawa,* Takako Isomae,* Ryuzaburo Mori,* Hiroyuki Shimada* and Izumi Utsunomiya

Mitsuko Yuzawa,* Takako Isomae,* Ryuzaburo Mori,* Hiroyuki Shimada* and Izumi Utsunomiya Surgical Excision Versus Laser Photocoagulation for Subfoveal Choroidal Neovascular Membrane with Age-related Macular Degeneration: Comparison of Visual Outcomes Mitsuko Yuzawa,* Takako Isomae,* Ryuzaburo

More information

Vascular Disease Ocular Manifestations of Systemic Hypertension

Vascular Disease Ocular Manifestations of Systemic Hypertension Vascular Disease Ocular Manifestations of Systemic Hypertension Maynard L. Pohl, OD, FAAO Pacific Cataract & Laser Institute 10500 NE 8 th Street, Suite 1650 Bellevue, WA 98004 USA 425-462-7664 Cerebrovascular

More information

The pinnacle of refractive performance.

The pinnacle of refractive performance. The pinnacle of refractive performance. WaveLight REFRACTIVE PORTFOLIO Advancing REFRACTIVE SURGERY Contoura Vision sets a new standard in LASIK outcomes More than 98% of patients would choose it again.

More information

Photodynamic Therapy for Treatment of Subfoveal Choroidal Neovascularization in Exudative Age-Related Macular Degeneration

Photodynamic Therapy for Treatment of Subfoveal Choroidal Neovascularization in Exudative Age-Related Macular Degeneration Clinical Medicine Journal Vol. 4, No. 4, 2018, pp. 60-66 http://www.aiscience.org/journal/cmj ISSN: 2381-7631 (Print); ISSN: 2381-764X (Online) Photodynamic Therapy for Treatment of Subfoveal Choroidal

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Koh A, Lai TYY, Takahashi K, et al; the EVEREST II Study Group. Efficacy and safety of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal

More information

Despite our growing knowledge of the

Despite our growing knowledge of the OVERVIEW OF AVAILABLE TREATMENTS FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION * Carl D. Regillo, MD ABSTRACT Although potential treatments for neovascular age-related macular degeneration represent

More information

Evaluation of Changes of Macular Thickness in Diabetic Retinopathy after Cataract Surgery

Evaluation of Changes of Macular Thickness in Diabetic Retinopathy after Cataract Surgery pissn: 1011-8942 eissn: 2092-9382 Korean J Ophthalmol 2011;25(4):238-242 DOI: 10.3341/kjo.2011.25.4.238 Evaluation of Changes of Macular Thickness in Diabetic Retinopathy after Cataract Surgery Original

More information

CLINICAL SCIENCES. Visual Outcomes Following Macular Translocation With 360 Peripheral Retinectomy

CLINICAL SCIENCES. Visual Outcomes Following Macular Translocation With 360 Peripheral Retinectomy CLINICAL SCIENCES Visual Outcomes Following Macular Translocation With 360 Peripheral Retinectomy James C. Lai, MD; Deborah J. Lapolice, MS; Sandra S. Stinnett, DrPH; Carsten H. Meyer, MD; Luz M. Arieu,

More information

Retinal Pigment Epithelial Tears (Rips) in the ERA of Anti Vegf - When and Why?

Retinal Pigment Epithelial Tears (Rips) in the ERA of Anti Vegf - When and Why? Original Article Retinal Pigment Epithelial Tears (Rips) in the ERA of Anti Vegf - When and Why? Dr Sreelekha S. MS, DNB, DO, FRCS, Dr Manoj Soman DNB, FICO, FRCS, Dr. Unni Nair MS, FRCS, Dr. Ruminder

More information

International Journal of Ophthalmic Research

International Journal of Ophthalmic Research International Journal of Ophthalmic Research Online Submissions: http://www.ghrnet.org/index./ijor/ doi:10.17554/j.issn.2409-5680.2017.03.55 Int. J. Ophthalmic Res 2017 June; 3(2): 226-230 ISSN 2409-5680

More information

PART 1: GENERAL RETINAL ANATOMY

PART 1: GENERAL RETINAL ANATOMY PART 1: GENERAL RETINAL ANATOMY General Anatomy At Ora Serrata At Optic Nerve Head Fundoscopic View Of Normal Retina What Is So Special About Diabetic Retinopathy? The WHO definition of blindness is

More information

Efficacy of Anti-VEGF Agents in the Treatment of Age-Related Macular Degeneration

Efficacy of Anti-VEGF Agents in the Treatment of Age-Related Macular Degeneration Efficacy of Anti-VEGF Agents in the Treatment of Age-Related Macular Degeneration Marilita M. Moschos Abstract- Purpose: To evaluate by OCT and mf-erg the macular function in eyes with CNV due to ARMD

More information

Optical Coherence Tomography: Pearls for the Anterior Segment Surgeon Basic Science Michael Stewart, M.D.

Optical Coherence Tomography: Pearls for the Anterior Segment Surgeon Basic Science Michael Stewart, M.D. Optical Coherence Tomography: Pearls for the Anterior Segment Surgeon Basic Science Michael Stewart, M.D. Disclosure OCT Optical Coherence Tomography No relevant financial relationships I will refer to

More information

International Journal of Health Sciences and Research ISSN:

International Journal of Health Sciences and Research   ISSN: International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article A Multivariate Analysis of Intravitreal Injection of Anti-VEGF Bevacizumab in the Treatment

More information

Neovascular Glaucoma Associated with Cilioretinal Artery Occlusion Combined with Perfused Central Retinal Vein Occlusion

Neovascular Glaucoma Associated with Cilioretinal Artery Occlusion Combined with Perfused Central Retinal Vein Occlusion Neovascular Glaucoma Associated with Cilioretinal Artery Occlusion Combined with Perfused Central Retinal Vein Occlusion Man-Seong Seo,* Jae-Moon Woo* and Jeong-Jin Seo *Department of Ophthalmology, Chonnam

More information

Diabetic Retinopathy

Diabetic Retinopathy Diabetic Retinopathy Diabetes mellitus is one of the leading causes of irreversible blindness worldwide. In the United States, it is the most common cause of blindness in people younger than 65 years.

More information

The limited number of currently approved

The limited number of currently approved CLINICAL TRIALS OF VERTEPORFIN AND PEGAPTANIB: WHAT ARE THE RESULTS? * William F. Mieler, MD ABSTRACT Currently available treatment options for the management of choroidal neovascularization (CNV) in age-related

More information

Photodynamic Therapy for Choroidal Neovascularization

Photodynamic Therapy for Choroidal Neovascularization Photodynamic Therapy for Choroidal Neovascularization Policy Number: 9.03.08 Last Review: 10/2014 Origination: 10/2000 Next Review: 10/2015 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will

More information

EPIRETINAL MEMBRANE & VITREOMACULAR TRACTION

EPIRETINAL MEMBRANE & VITREOMACULAR TRACTION EPIRETINAL MEMBRANE & VITREOMACULAR TRACTION Management of ERM and VMT K.V.Chalam,MD,PhD,MBA,FACS Professor and Director of Retina Loma Linda Eye Institute Los Angeles, USA REVIEW ANATOMY The vitreous

More information

A Patient s Guide to Diabetic Retinopathy

A Patient s Guide to Diabetic Retinopathy Diabetic Retinopathy A Patient s Guide to Diabetic Retinopathy 840 Walnut Street, Philadelphia PA 19107 www.willseye.org Diabetic Retinopathy 1. Definition Diabetic retinopathy is a complication of diabetes

More information

Scott M. Pfahler D.O. Dayton Vitreo-Retinal Associates AOCOO-HNS Palm Springs, CA 2012

Scott M. Pfahler D.O. Dayton Vitreo-Retinal Associates AOCOO-HNS Palm Springs, CA 2012 Scott M. Pfahler D.O. Dayton Vitreo-Retinal Associates AOCOO-HNS Palm Springs, CA 2012 Proliferative Diabetic Retinopathy Laser Treatments Medical Treatment Surgical Treatment Diabetic Macular Edema Laser

More information

COEXISTENCE OF OPTIC NERVE HEAD DRUSEN

COEXISTENCE OF OPTIC NERVE HEAD DRUSEN COEXISTENCE OF OPTIC NERVE HEAD DRUSEN AND COMBINED HAMARTOMA OF THE RETINA AND RETINAL PIGMENT EPITHELIUM IN A TAIWANESE MALE Yo-Chen Chang 1 and Rong-Kung Tsai 2,3 1 Department of Ophthalmology, Kaohsiung

More information

Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin

Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin Graefe s Arch Clin Exp Ophthalmol (2005) 243: 973 979 CLINICAL INVESTIGATION DOI 10.1007/s00417-005-1139-4 Rufino M. Silva João Figueira M. Luz Cachulo Liliane Duarte José R. Faria de Abreu J. G. Cunha-Vaz

More information

ROLE OF LASER PHOTOCOAGULATION VERSUS INTRAVITREAL TRIAMCINOLONE ACETONIDE IN ANGIOGRAPHIC MACULAR EDEMA IN DIABETES MELLITUS

ROLE OF LASER PHOTOCOAGULATION VERSUS INTRAVITREAL TRIAMCINOLONE ACETONIDE IN ANGIOGRAPHIC MACULAR EDEMA IN DIABETES MELLITUS ORIGINAL ARTICLE ROLE OF LASER PHOTOCOAGULATION VERSUS INTRAVITREAL TRIAMCINOLONE ACETONIDE IN ANGIOGRAPHIC MACULAR EDEMA IN DIABETES MELLITUS Aggarwal Somesh VP 1, Shah Sonali N 2, Bharwada Rekha M 3,

More information

Optometric Postoperative Cataract Surgery Management

Optometric Postoperative Cataract Surgery Management Financial Disclosures Optometric Postoperative Cataract Surgery Management David Dinh, OD Oak Cliff Eye Clinic Dallas Eye Consultants March 10, 2015 Comanagement Joint cooperation between two or more specialists

More information

Fluorescein Angiography

Fluorescein Angiography Last revision: October 2011 by Luis Arias Fluorescein Angiography Authors: Luis Arias, MD Hospital Universitari de Bellvitge - University of Barcelona. Spain Jordi Monés, MD Institut de la Màcula i de

More information

FEP Medical Policy Manual

FEP Medical Policy Manual FEP Medical Policy Manual Last Review: September 2016 Next Review: September 2017 Related Policies 9.03.20 Intraocular Radiation Therapy for Age-Related Macular Degeneration Photodynamic Therapy for Choroidal

More information

LIX EDWARD JACKSON MEMORIAL LECTURE Pathologic Myopia: Where Are We Now?

LIX EDWARD JACKSON MEMORIAL LECTURE Pathologic Myopia: Where Are We Now? LIX EDWARD JACKSON MEMORIAL LECTURE Pathologic Myopia: Where Are We Now? YASUO TANO, MD PURPOSE: To describe current concepts and available treatments for pathologic myopia. DESIGN: Review of experimental

More information

Clinical Policy: Neovascular (WET) Macular Degeneration Treatment Reference Number: CP.MP.283

Clinical Policy: Neovascular (WET) Macular Degeneration Treatment Reference Number: CP.MP.283 Clinical Policy: Neovascular (WET) Macular Degeneration Treatment Reference Number: CP.MP.283 Effective Date: 11/16 Last Review Date: 11/17 See Important Reminder at the end of this policy for important

More information

Fundamentals of Retina Coding

Fundamentals of Retina Coding Fundamentals of Retina Coding Presented by: Joy Woodke, COE, OCS Sunday, April 2, 2017 ASRS Business of Retina Meeting Dallas, TX American Academy of Ophthalmic Executives Financial Disclosure Joy Woodke,

More information

Description of iatrogenic corneal ectasia in patients without traditional risk factors

Description of iatrogenic corneal ectasia in patients without traditional risk factors ARTICLE Description of iatrogenic corneal ectasia in patients without traditional risk factors Julio Ortega-Usobiaga, MD, PhD 1 ; Rosario Cobo-Soriano, MD, PhD 1 ; Fernando Llovet-Osuna, MD, PhD 1 ; Stephan

More information

References 1. Melberg NS, Thomas MA AJO 120: , Welch JC AJO 124: 698, Hirata A, Yonemura N, et al. AJO 130:611, 2000.

References 1. Melberg NS, Thomas MA AJO 120: , Welch JC AJO 124: 698, Hirata A, Yonemura N, et al. AJO 130:611, 2000. Central or Paracentral Scotoma Associated with Nasal Placement of Chandelier Infusion During Vitrectomy with Fluid-Air Exchange J. Michael Jumper MD, Sara J. Haug MD PhD, Arthur D. Fu MD, Robert N. Johnson

More information

Diagnosis and treatment of diabetic retinopathy. Blake Cooper MD Ophthalmologist Vitreoretinal Surgeon Retina Associates Kansas City

Diagnosis and treatment of diabetic retinopathy. Blake Cooper MD Ophthalmologist Vitreoretinal Surgeon Retina Associates Kansas City Diagnosis and treatment of diabetic retinopathy Blake Cooper MD Ophthalmologist Vitreoretinal Surgeon Retina Associates Kansas City Disclosures Consulted for Novo Nordisk 2017,2018. Will be discussing

More information

Posterior Vitreomacular Adhesion and Risk of Exudative Age-related Macular Degeneration : Paired Eye Study

Posterior Vitreomacular Adhesion and Risk of Exudative Age-related Macular Degeneration : Paired Eye Study Posterior Vitreomacular Adhesion and Risk of Exudative Age-related Macular Degeneration : Paired Eye Study Sung Jun Lee Department of Medicine The Graduate School, Yonsei University Posterior Vitreomacular

More information

Transpupillary thermotherapy (TTT) for the treatment of choroidal neovascularisation

Transpupillary thermotherapy (TTT) for the treatment of choroidal neovascularisation Br J Ophthalmol 2001;85:173 178 173 King s College Hospital, Denmark Hill, London SE5 9RS, UK R S B Newsom J C McAlister M Saeed J D A McHugh Correspondence to: Mr R S B Newsom, Department of Vitreoretinal

More information

Original Article High myopia as a risk factor for post-lasik ectasia: a case report

Original Article High myopia as a risk factor for post-lasik ectasia: a case report Original Article High myopia as a risk factor for post-lasik ectasia: a case report Mona Harissi-Dagher, MD, a,b Sonja A. F. Frimmel, c and Samir Melki, MD, PhD a,d Author affiliations: a Massachusetts

More information

Description. Section: Other Effective Date: July 15, Subsection: Vision Original Policy Date: December 7, 2011 Subject: Page: 1 of 23

Description. Section: Other Effective Date: July 15, Subsection: Vision Original Policy Date: December 7, 2011 Subject: Page: 1 of 23 Last Review Status/Date: June 2015 Page: 1 of 23 Description Photodynamic therapy (PDT) is a treatment modality designed to selectively occlude ocular choroidal neovascular tissue. The therapy is a 2-step

More information

LASERS AND LATTE Richard G. Orlando, M.D., F.A.C.S.

LASERS AND LATTE Richard G. Orlando, M.D., F.A.C.S. LASER LASERS AND LATTE Richard G. Orlando, M.D., F.A.C.S. Light Amplification by Stimulated Emission of Radiation Photons are in phase to produce high intensity polarized light Modification by shutters

More information

Recent concerns regarding the depth of tissue ablation with

Recent concerns regarding the depth of tissue ablation with Volume Estimation of Excimer Laser Tissue Ablation for Correction of Spherical Myopia and Hyperopia Damien Gatinel, 1 Thanh Hoang-Xuan, 1 and Dimitri T. Azar 1,2 PURPOSE. To determine the theoretical volumes

More information

Macular conditions. by Louise Stainer BSc(Hons)

Macular conditions. by Louise Stainer BSc(Hons) 4 dispensingoptics December 2013 Macular conditions by Louise Stainer BSc(Hons) CompetencIes covered: Dispensing opticians: Ocular Examination, Ocular Abnormalities, Low Vision Optometrists: Ocular Disease

More information

EFFICACY OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS IN RETINAL DISORDER FOR BETTER VISUAL ACUITY

EFFICACY OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS IN RETINAL DISORDER FOR BETTER VISUAL ACUITY EFFICACY OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS IN RETINAL DISORDER FOR BETTER VISUAL ACUITY Diwakar chaudhary *1, 2, Hu shuqiong, Long Yuan and Xiong kun 1 Yangtze University, 1 Nanhuan Road

More information

Eyes on Diabetics: How to Avoid Blindness in Diabetic Patient

Eyes on Diabetics: How to Avoid Blindness in Diabetic Patient Eyes on Diabetics: How to Avoid Blindness in Diabetic Patient Rova Virgana FK Unpad Pusat Mata Nasional RS Mata Cicendo Bandung Eye Center (Hospital and Clinic) PIT IDI Jabar 2018 Keys Facts from WHO

More information

Misdiagnosed Vogt-Koyanagi-Harada (VKH) disease and atypical central serous chorioretinopathy (CSC)

Misdiagnosed Vogt-Koyanagi-Harada (VKH) disease and atypical central serous chorioretinopathy (CSC) HPTER 12 Misdiagnosed Vogt-Koyanagi-Harada (VKH) disease and atypical central serous chorioretinopathy (S) linical Features VKH disease is a bilateral granulomatous panuveitis often associated with exudative

More information